ANI Pharmaceuticals Ownership | Who Owns ANI Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

ANI Pharmaceuticals Ownership Summary


ANI Pharmaceuticals is owned by 96.52% institutional investors, 10.66% insiders. Blackrock is the largest institutional shareholder, holding 13.91% of ANIP shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.67% of its assets in ANI Pharmaceuticals shares.

ANIP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockANI Pharmaceuticals96.52%10.66%-7.18%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustrySpecialty & Generic Drug Manufacturers Stocks44.00%11.78%44.23%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock2.66M13.91%$169.17M
Blackrock funding, inc. /de2.55M12.85%$233.48M
Vanguard group1.28M6.44%$117.02M
Millennium management1.00M5.17%$55.44M
State street737.29K3.80%$40.76M
Goldman sachs group699.62K3.61%$38.67M
Deep track capital, lp700.00K3.53%$45.67M
Global alpha capital management630.59K3.18%$57.76B
Ubs group589.87K2.97%$54.03M
Dimensional fund advisors lp505.43K2.55%$46.30M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Global alpha capital management630.59K3.30%$57.76B
Apis capital advisors128.00K2.97%$8.35M
Decker retirement planning36.94K1.86%$3.38M
Lisanti capital growth82.55K1.85%$7.56M
Ranger investment management271.35K1.73%$24.86M
Deep track capital, lp700.00K1.46%$45.67M
Sio capital management55.72K1.29%$5.10M
Marathon capital management72.03K1.20%$4.70M
Tang capital management317.50K1.05%$20.72M
Parkman healthcare partners128.48K0.96%$8.38M

Top Buyers

HolderShares% AssetsChange
Millennium management1.00M0.03%473.10K
Arrowstreet capital, limited partnership360.18K0.02%360.18K
Divisadero street capital management, lp234.22K0.94%234.22K
Freestone grove partners lp195.21K0.10%191.22K
Bnp paribas arbitrage, snc227.54K0.01%189.54K

Top Sellers

HolderShares% AssetsChange
Ranger investment management271.35K1.73%-262.89K
Global alpha capital management630.59K3.30%-231.50K
Soleus capital management50.74K0.22%-173.94K
Woodline partners lp---166.45K
Thompson siegel & walmsley91.43K0.14%-152.99K

New Positions

HolderShares% AssetsChangeValue
Arrowstreet capital, limited partnership360.18K0.02%360.18K$32.99M
Divisadero street capital management, lp234.22K0.94%234.22K$21.45M
Pdt partners45.44K0.17%45.44K$2.97M
Marshall wace, llp30.19K0.00%30.19K$2.77M
Amundi23.63K0.00%23.63K$1.54M

Sold Out

HolderChange
Mendota financial group-1.00
Harbour investments-1.00
Financial gravity asset management-1.00
Nelson, van denburg & campbell wealth management group-1.00
Cbiz investment advisory services-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025224-2.18%19,142,922-4.15%960.93%1145.56%70-4.11%
Mar 31, 202522911.16%19,974,4243.61%1011.03%11011.11%7220.00%
Dec 31, 2024203-3.33%19,272,0261.94%991.05%98-21.60%5937.21%
Sep 30, 20242091.95%18,894,59324.90%971.55%12516.82%43-30.65%
Jun 30, 2024203-1.46%15,126,9587.17%791.45%105-2.78%6219.23%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.01M4.67%-
Vanguard US Total Market Shares ETF588.25K2.73%-
Vanguard Total Stock Mkt Idx Inv587.04K2.70%-13.01K
Pacer US Small Cap Cash Cows 100 ETF549.63K2.62%-1.87K
iShares Russell 2000 ETF439.65K2.03%-
CC&L Global Alpha - Series A375.10K1.73%-7.20K
Ranger Small Cap359.19K1.66%-19.61K
Delaware Ivy Small Cap Growth C336.40K1.60%-
AZ InvestEd Ivy Small Cap Growth E264.83K1.22%-
Macquarie Small Cap Growth C264.83K1.22%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 13, 2025Cook Meredith SR. VP, GENERAL COUNSEL & SEC.Sell$36.04K
Sep 19, 2025Davis Krista SVP, CHIEF HR OFFICERSell$98.04K
Sep 12, 2025Cook Meredith SR. VP, GENERAL COUNSEL & SEC.Sell$39.37K
Sep 03, 2025Pera Antonio R-Sell$692.30K
Aug 25, 2025Leonard Matthew J-Sell$229.09K

Insider Transactions Trends


DateBuySell
2025 Q4-1
2025 Q3-22
2025 Q2-6
2025 Q1-8
2024 Q4-8

ANIP Ownership FAQ


Who Owns ANI Pharmaceuticals?

ANI Pharmaceuticals shareholders are primarily institutional investors at 96.52%, followed by 10.66% insiders and -7.18% retail investors. The average institutional ownership in ANI Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 44.00%, which ANI Pharmaceuticals exceeds.

Who owns the most shares of ANI Pharmaceuticals?

ANI Pharmaceuticals’s largest shareholders are Blackrock (2.66M shares, 13.91%), Blackrock funding, inc. /de (2.55M shares, 12.85%), and Vanguard group (1.28M shares, 6.44%). Together, they hold 33.20% of ANI Pharmaceuticals’s total shares outstanding.

Does Blackrock own ANI Pharmaceuticals?

Yes, BlackRock owns 13.91% of ANI Pharmaceuticals, totaling 2.66M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 169.17M$. In the last quarter, BlackRock increased its holdings by 125.17K shares, a 4.94% change.

Who is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Global alpha capital management is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.30% of its assets in 630.59K ANI Pharmaceuticals shares, valued at 57.76B$.

Who is the top mutual fund holder of ANI Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ANI Pharmaceuticals shares, with 4.67% of its total shares outstanding invested in 1.01M ANI Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools